Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function
Version 2 2024-05-30, 15:28
Version 1 2014-10-28, 09:59
journal contribution
posted on 2024-05-30, 15:28 authored by J Hodge, Y Wang, Michael BerkMichael Berk, Fiona CollierFiona Collier, T Fernandes, M Constable, Julie PascoJulie Pasco, Seetal DoddSeetal Dodd, G Nicholson, Lee KennedyLee Kennedy, Lana WilliamsLana WilliamsSelective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function
History
Journal
Biological psychiatryVolume
74Pagination
32-39Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
0006-3223eISSN
1873-2402Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2013, ElsevierIssue
1Publisher
ElsevierPublication URL
Usage metrics
Categories
No categories selectedKeywords
antidepressantapoptosisboneosteoblastosteoclastosteoporosisselective serotonin reuptake inhibitorScience & TechnologyLife Sciences & BiomedicineNeurosciencesPsychiatryNeurosciences & NeurologyAntidepressantBONE-MINERAL DENSITYCENTRAL-NERVOUS-SYSTEMTRICYCLIC ANTIDEPRESSANTSIN-VITROCELL-PROLIFERATIONINDUCED APOPTOSISOLDER WOMENMAP KINASEFLUOXETINEEXPRESSIONNHMRC 1009367NHMRC 628582970111 Expanding Knowledge in the Medical and Health Sciences110319 Psychiatry (incl Psychotherapy)111714 Mental Health920410 Mental HealthInnovation in Mental and Physical Health and Clinical TreatmentSchool of MedicineFaculty of Health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC